Medtronic (MDT)Rep. Kevin Hern (OK01) disclosed a sale $15K–$50K
Rep. Kevin Hern (OK01) disclosed a sale of Medtronic in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 8 days
- Disclosure lag
- Traded
- Aug 24, 2026
- Disclosed
- Sep 1, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
- Jul 9, 2026FDAFDA device clearance: SmartGuard Technology; Predictive Low Glucose Technology
- Jul 13, 2026FDARecall: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW
- Jul 13, 2026FDARecall: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
- Jul 13, 2026FDARecall: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
- Jul 14, 2026FDAFDA device clearance: Symmetrix L Spinal System
- Jul 17, 2026FDAFDA device clearance: Catalyft PL Expandable Interbody System
- Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
- Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance Biosurface
- Aug 13, 2026FDAFDA device clearance: BIS Advance pEEG Module
- Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
- Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
- Aug 24, 2026 · this disclosureCongressDisclosed sale of MDT — reported range $15,001 - $50,000
What came next
- Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
- Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 4, 2026FDAFDA device clearance: ApexCut Blade with Automated EM Tracking (187BL4012EM);ApexCut Blade with Automated EM Tracking (187BL4040EM);ApexCut Blade with Automated EM Tracking (1…
- Sep 15, 2026FDAFDA device clearance: LigaSure RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
- Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
- Sep 17, 2026FDAFDA device clearance: Protégé EverFlex Self-expanding Peripheral Stent System
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Medtronic
For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
Other recent filings by Rep. Kevin Hern (OK01)
- House Clerk periodic transaction report at Boston Scientific (BSX)Sep 25, 2026
- House Clerk periodic transaction report at Boston Scientific (BSX)Sep 25, 2026
- House Clerk periodic transaction report at Cadence Design Systems (CDNS)Sep 25, 2026
- House Clerk periodic transaction report at Progress Software Corporation (PRGS)Sep 25, 2026
- House Clerk periodic transaction report at Coca-Cola (KO)Sep 25, 2026
The full history of Rep. Kevin Hern (OK01) is on the profile page.
How this filing works
Other disclosures at Medtronic
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
- SEC Form 13F-HRAug 26, 2026
- House Clerk periodic transaction reportAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
